ALEXANDRIA, Va., May 26 -- United States Patent no. 12,636,356, issued on May 26, was assigned to EVELIQURE BIOTECHNOLOGIES GMBH (Vienna).
"High dose shigella vaccine preparation" was invented by Eszter Nagy (Vienna), Tamas Henics (Vienna), Petra Girardi (Vienna), Irene Neuhauser (Vienna), Shushan Harutyunyan (Vienna), Gabor Nagy (Sopron, Hungary) and Valeria Szijarto (Vienna).
According to the abstract* released by the U.S. Patent & Trademark Office: "A Shigella vaccine preparation comprising 10E8-10E12 CFU of a live, genetically attenuated Shigella flexneri strain that comprises a chromosomal deletion of setBA and which is non-invasive as determined by the Sereny test and an in vitro invasion assay using HeLa cells, wherein the strain c...